0 CHECKOUT

China Human Vaccine Industry Report, 2016-2020 (Chinese Version)

  • ID: 3771357
  • June 2016
  • Region: China
  • 151 Pages
  • Research In China
1 of 4
China’s Human Vaccine Lot Release Volume in 2015 Fell by 17.9% Year on Year to Only 650 Million Doses,Touching a 5-Year Low

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses, touching a 5-year low. Moreover, with the improvements in domestic vaccine supply capacity and vaccine circulation safety, China’s human vaccine import volume has showed a year-by-year decline in recent years, with the imports for 2015 totaling 173.9 tons, down 17.5% year on year.

Affected by China’s less-developed economy, existing national vaccine prevention policies and people’s awareness of epidemic prevention, free EPI vaccines prevail in China. But the market share is falling, with the free EPI vaccine lot release volume in 2015 accounting for about 74.3% of the total.

The Chinese free human vaccine market is still dominated by the subsidiaries of China National Biotec Group - including Beijing Tiantan Biological Products, Chengdu Institute of Biological Products Co., Ltd., Shanghai Institute of Biological Products Co., Ltd., Lanzhou Institute of Biological Products Co., Ltd., Wuhan Institute of Biological Products Co., Ltd., and Changchun Institute of Biological Products Co., Ltd. -and state-owned READ MORE >

Note: Product cover images may vary from those shown
2 of 4

1. Overview of Vaccine Industry
1.1 Definition & Classification
1.2 Industry Chain

2. China Human Vaccine Industry & Market
2.1 Overview
2.2 Operating Environment
2.2.1 International Market
2.2.2 Policy Environment
2.2.3 Biopharmaceutical Market in China
2.3 Status Quo
2.4 Supply & Demand
2.5 Competition Pattern
2.6 Dynamics
2.7 Sales Channel

3. Human Vaccine Market Segments in China
3.1 Hepatitis B Vaccine
3.1.1 Supply & Demand
3.1.2 Competition Pattern
3.1.3 Market Price
3.2 Meningococcal Vaccines
3.2.1 Supply & Demand
3.2.2 Competition Pattern
3.2.3 Market Price
3.2.4 Market Forecast
3.3 Hepatitis A Vaccine
3.3.1 Supply & Demand
3.3.2 Competition Pattern
3.3.3 Market Price
3.3.4 Market Forecast
3.4 Influenza Vaccine
3.4.1 Supply & Demand
3.4.2 Competition Pattern
3.4.3 Market Price
3.5 Hib Vaccine
3.5.1 Supply & Demand
3.5.2 Competition Pattern
3.5.3 Market Price
3.5.4 Market Forecast
3.6 Rabies Vaccine
3.6.1 Supply & Demand
3.6.2 Competition Pattern
3.6.3 Market Price
3.6.4 Market Forecast
3.7 Varicella Vaccine
3.7.1 Supply & Demand
3.7.2 Competition Pattern
3.7.3 Market Price
3.8 Pneumococcal Vaccines
3.8.1 Supply & Demand
3.8.2 Competition Pattern
3.8.3 Market Price
3.9 DTP Vaccine
3.9.1 Supply & Demand
3.9.2 Competition Pattern
3.9.3 Market Dynamics & Forecast
3.10 PoliomyelitisVaccine
3.10.1 Supply & Demand
3.10.2 Competition Pattern

4. China’s Import and Export of Vaccines
4.1 Export
4.1.1 Export Volume and Value
4.1.2 Export Country and Region
4.2 Import
4.2.1 Import Volume and Value
4.2.2 Import Country and Region

5. Major Vaccine Manufacturers in China
5.1 China National Biotec Group
5.1.1 Beijing Tiantan Biological Products Co., Ltd
5.1.2 Chengdu Institute of Biological Products Co., Ltd.
5.1.3 Shanghai Institute of Biological Products Co., Ltd.
5.1.4 Wuhan Institute of Biological Products Co., Ltd.
5.1.5 Lanzhou Institute of Biological Products Co., Ltd.
5.1.6 Changchun Institute of Biological Products Co., Ltd.
5.2 Hualan Biological Engineering Inc.
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 Clients and Suppliers
5.2.6 R&D Cost and Investment
5.2.7 Vaccine Business
5.2.8 Development and Prospects
5.3 Chongqing Zhifei Biological Products Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 Clients
5.3.6 R&D Cost and Investment
5.3.7 Development and Prospects
5.4 Walvax Biotechnology Co, Ltd.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Clients and Suppliers
5.4.6 R&D Cost and Investment
5.4.7 Development and Prospects
5.5 Sinovac Biotech Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 R&D Cost and Investment
5.5.5 Development and Prospects
5.6 Liaoning Cheng Da Co., Ltd.
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Clients
5.6.6 Liaoning Chengda Biotechnology Co., Ltd.
5.6.7 Development and Prospects
5.7 Changchun BCHT Biotechnology Co. Ltd.
5.7.1 Profile
5.7.2 Operation
5.8 Changchun Changsheng Life Sciences Limited
5.8.1 Profile
5.8.2 Operation
5.9 Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
5.9.1 Profile
5.9.2 Operation
5.10 Shenzhen Kangtai Biological Products Co. Ltd.
5.10.1 Profile
5.10.2 Operation
5.11 Dalian Hissen Bio-Pharm Co., Ltd.
5.11.1 Profile
5.11.2 Operation
5.12 NCPC GeneTech Biotechnology Development Co., Ltd.
5.12.1 Profile
5.12.2 Operation
5.13 Dalian Aleph Biomedical Co., Ltd.
5.13.1 Profile
5.13.2 Operation
5.14 Beijing Minhai Biotechnology Co., Ltd.
5.14.1 Profile
5.14.2 Operation
5.15 Shenzhen Sanofi Pasteur Biological Products Co., Ltd.
5.15.1 Profile
5.15.2 Operation
5.16 Jiangsu SimcereVaxtec Bio-pharmaceutical Co., Ltd.

List of Charts

- Classification of Vaccines
- Vaccine Industry Chain
- EPI Human Vaccine Varieties in China, 2015
- Global Human Vaccine Market Scale, 2008-2015
- Sales Value of the Global Top 5 Human Vaccine Manufacturers, 2008-2015
- Main Mergers & Acquisitions in the Vaccine Industry Worldwide, 2005- 2015
- Policies in Vaccine Industry
- Revenue and Total Profit of Bio-pharmaceutical Industry in China, 2007-2014
- China’s Human Vaccine Market Scale, 2007-2015
- Major Human Vaccine Varieties and Producers in China
- Gross Margin of Major Human Vaccine Manufacturers in China, 2007-2015
- The Release and Percentage (by Volume) of EPI and Extra EPI Vaccines in China, 2007-2015
- China’s EPI Human Vaccine Market Shares by Release, 2008-2015 (by Enterprise Property)
- China’s Extra EPI Human Vaccine Market Shares by Release, 2008-2015 (by Enterprise Property)
- Vaccine Revenue of Major Vaccine Enterprises in China, 2011-2015
- Some Events Related to Vaccine Business of Foreign Enterprises in China, 2011-2015
- Vaccine Distribution Channel in China
- Lot Release Volume of Hepatitis B Vaccine in China by Dosage Form, 2007-2015
- Hepatitis B Vaccine (CHO Cell) Suppliers and Lot Release Volume in China, 2008-2015
- Hepatitis B Vaccine (Yeast) Suppliers and Lot Release Volume in China, 2007-2015
- Market Prices of Hepatitis B Vaccine in Some Regions of China, 2014
- Meningitis Morbidity and Mortality in China, 2008-2014
- Meningococcal Vaccines Lot Release Volume in China by Type, 2007-2015
- Suppliers and Lot Release Volume of A-Group Meningococcal Vaccines, 2007-2015
- Suppliers and Lot Release Volume of A-Group Meningococcal Vaccine, 2009-2015
- Suppliers and Lot Release Volume of A+C meningococcal vaccines, 2007-2015
- Suppliers and Lot Release Volume of ACYW135 Meningococcal Vaccines in China, 2008-2015
- Market Prices of Meningococcal Vaccines in Some Regions of China, 2015
- Hepatitis A Morbidity and Mortality in China, 2008-2013
- Hepatitis A Vaccine Lot Release Volume in China, 2007-2015
- Hepatitis A Vaccine Suppliers and Lot Release Volume in China, 2007-2015
- Market Price of Hepatitis A Vaccine in China, 2015
- Consumption Forecast of Hepatitis A Vaccine in China, 2015-2020
- Influenza Morbidity and Mortality in China, 2008-2013
- H1N1 Influenza Morbidity and Mortality in China, 2009-2012
- China’s Influenza Vaccine Lot Release Volume (by Type), 2007-2015
- Suppliers and Lot Release Volume of Influenza Split Vaccine in China, 2007-2015
- Influenza Subunit Vaccine Suppliers and Lot Release Volume in China, 2007-2012
- Market Price of Influence Vaccine in China, 2015
- Hib Vaccine Lot Release Volume in China, 2007-2015
- Hib Vaccin Suppliers and Lot Release Volume in China, 2007-2015
- Market Prices of Hib Vaccine in Some Regions of China, 2015
- Sales Volume of Hib Vaccine in China, 2015-2020 (mln dosages)
- Rabies Morbidity and Mortality in China, 2007-2014
- Human Rabies Vaccine Lot Release Volume in China, 2007-2015
- Human Rabies Vaccine Lot Release Volume in China by Type, 2007-2015
- Human Vero Cell Rabies Vaccine Suppliers and Lot Release Volume in China, 2007-2015
- Human BHK Cell Rabies Vaccine Suppliers and Lot Release Volume in China, 2007-2015
- Market Price of Human Rabies Vaccines in Some Provinces/Cities of China, 2015
- Demand Forecast of Human Rabies Vaccine in China, 2015-2020(mln person-portions)
- Varicella Vaccine Lot Release Volume in China, 2007-2015
- Suppliers and Lot Release Volume of Varicella Vaccine in China, 2007-2015
- Market Price of Varicella Vaccine in Some Regions of China, 2015
- Pneumococcal Vaccines Lot Release Volume in China, 2007-2015
- Suppliers of 7-valent and 23-valent Pneumococcal Vaccines and Their Lot Release Quantities in China, 2007-2015
- Market Prices of Pneumococcal Vaccines in Some Regions of China, 2015
- DTP Vaccine Lot Release Volume in China, 2007-2015
- DTPa Vaccine Suppliers and Lot Release Volume in China, 2007-2015
- Poliomyelitis Vaccine Lot Release Volume in China, 2007-2015
- Poliomyelitis Vaccine Suppliers and Lot Release Volume in China, 2007-2015
- Export Volume and Value of Human Vaccine in China, 2009- 2015
- Export Average Unit Price of Human Vaccine in China, 2009- 2015
- China’s Human Vaccine Export Volume and Value by Country, 2015
- Import Volume and Value of Human Vaccine in China, 2009-2015
- Import Average Unit Price of Human Vaccine in China, 2009- 2015
- China’s Human Vaccine Import Volume and Value by Country, 2015
- Major Shareholding Companies of Tiantan Biological and Their Revenue, Net Income, 2015
- Revenue and Operating Income of Beijing Tiantan Biological Products, 2009-2016
- Revenue Breakdown of Beijing Tiantan Biological Products by Sector, 2008-2015
- Revenue Breakdown of Beijing Tiantan Biological Products by Region, 2007-2015
- Beijing Tiantan Biological Products’ Procurement from Top 5 Suppliers and % of Total Procurement, 2008-2015
- Beijing Tiantan Biological Products’ Revenue from Top5 Customers and % of Total Revenue, 2008-2015
- Gross Margin of Beijing Tiantan Biological Products by Sector, 2008-2015
- R&D Costs and % of Total Revenue of Beijing Tiantan Biological Products, 2009-2015
- Main R&D Products and Progress of Beijing Tiantan Biological Products as of the end of 2015
- Vaccine Revenue of Beijing Tiantan Biological Products, 2008-2015
- Vaccine Lot Release Volume Breakdown of Beijing Tiantan Biological Products by Product, 2009-2015
- Revenue and Operating Income of Beijing Tiantan Biological Products, 2015-2020E
- Vaccine Varieties of Chengdu Institute of Biological Products
- Vaccine Lot Release Volume Breakdown of Chengdu Institute of Biological Products by Product, 2009-2015
- Vaccine Varieties of Shanghai Institute of Biological Products
- Vaccine Lot Release Volume Breakdown of Shanghai Institute of Biological Products by Product, 2009-2015
- Vaccine Lot Release Volume Breakdown of Wuhan Institute of Biological Products by Product, 2009-2015
- Vaccine Lot Release Volume Breakdown of Lanzhou Institute of Biological Products by Product, 2009-2015
- Vaccine Lot Release Volume Breakdown of Changchun Institute of Biological Products by Product, 2009-2015
- Revenue and Operating Income of Hualan Biological Engineering, 2007-2016
- Revenue Breakdown of Hualan Biological Engineering by Sector, 2008-2015
- Gross Margin of Hualan Biological Engineering by Product, 2007-2014
- Hualan Biological Engineering’s Revenue from Top5 Customers and % of Total Revenue, 2008-2015
- Hualan Biological Engineering’s Procurement from Top 5 Suppliers and % of Total Procurement, 2008-2015
- Name List, Procurement Amount of Top 5 Suppliers and % of Total Procurement, 2015
- R&D Costs and % of Total Revenue of Hualan Biological Engineering, 2008-2015
- Lot Release Volume Breakdown of Hualan Biological Engineering by Product, 2011-2015
- Vaccine Revenue and Gross Margin of Hualan Biological Engineering, 2008-2015
- Revenue and Operating Income of Hualan Biological Engineering, 2015-2020E
- Revenue and Operating Income of Chongqing Zhifei Biological Products, 2008-2016
- Revenue Breakdown of Chongqing Zhifei Biological Products by Product, 2011-2015
- Lot Release Volume Breakdown of Chongqing Zhifei Biological Products by Product, 2011-2015
- Revenue Breakdown of Chongqing Zhifei Biological Products by Region, 2009-2015
- Gross Margin of Chongqing Zhifei Biological Products, 2009-2015
- Gross Margins of Chongqing Zhifei Biological Products’ Home-grown Vaccines, 2008-2015
- Gross Margins of Chongqing Zhifei Biological Products’ Agent Vaccines, 2008-2015
- Chongqing Zhifei Biological Products’ Revenue from Top5 Customers and % of Total Revenue, 2008-2015
- Procurement Amount and % of Total Procurement of Chongqing Zhifei Biological Products’ Top5 Suppliers, 2012-2015
- R&D Costs and % of Total Revenue of Chongqing Zhifei Biological Products, 2008-2015
- Progress of Some Products under Research of Chongqing Zhifei Biological Products by the end of 2015
- Revenue and Operating Income of Chongqing Zhifei Biological Products, 2015-2020E
- Industrial Layout of Walvax Biotechnology
- Revenue and Operating Income of Walvax Biotechnology, 2009-2015
- Vaccines on the Market and Capacities of Walvax Biotechnology
- Revenue Breakdown of Walvax Biotechnology by Product, 2009-2015
- Lot Release Volume Breakdown of Walvax Biotechnology by Product, 2009-2015
- Revenue Breakdown of Walvax Biotechnology by Region, 2010-2015
- Gross Margin of Walvax Biotechnology by Product, 2007-2015
- Walvax Biotechnology’s Revenue from Top5 Customers and % of Total Revenue, 2008-2015
- Walvax Biotechnology’s Procurement from Top5 Suppliers and % of Total Procurement, 2008-2015
- Progress of Projects under Construction of Walvax Biotechnology by the end of 2015
- R&D Costs and % of Total Revenue of Walvax Biotechnology, 2009-2015
- Progress of the Products under Research of Walvax Biotechnology by the end of 2015
- Revenue and Operating Income of Walvax Biotechnology, 2015-2020E
- Revenue and Profit of Sinovac Biotech, 2007-2016
- Revenue Breakdown of Sinovac Biotech by Product, 2008-2015 (Unit: USD mln)
- Vaccine Lot Release Volume Breakdown of Sinovac Biotech by Product, 2009-2015
- R&D Costs and % of Total Revenue of Sinovac Biotech, 2008-2015
- Revenue and Operating of Sinovac Biotech, 2015-2020E
- Revenue and Operating Income of Liaoning Chengda, 2008-2016
- Revenue Breakdown of Liaoning Chengda by Sector, 2008-2015
- Revenue Breakdown of Liaoning Chengda by Region, 2008-2015
- Gross Margin of Liaoning Chengda by Sector, 2008-2015
- Liaoning Chengda’s Revenue from Top5 Customers and % of Total Revenue, 2008-2015
- Human Vaccine Lot Release Volume of Liaoning Chengda Biotechnology, 2009-2015
- Revenue and Net Income of Liaoning Chengda Biotechnology, 2012-2015
- Revenue Structure of Liaoning Chengda Biotechnology by Product, 2012-2015
- Name List and Revenue Contribution of Liaoning Chengda Biotechnology’s Top5 Customers, 2013-2015
- Name List and Procurement Share of Liaoning Chengda Biotechnology’s Top5 Suppliers, 2013-2015
- Revenue and Operating Income of Liaoning Chengda, 2015-2020E
- Revenue and Operating Income of Changchun BCHT, 2009-2015
- Vaccine Lot Release Volume and Percentage of Changchun BCHT, 2009-2015
- Vaccine Lot Release Volume Breakdown of Changchun Changsheng Biotechnology by Product, 2009-2015
- Vaccine Lot Release Volume and Percentage of Zhejiang Tianyuan Bio-Pharmaceutical, 2008-2015
- Revenue and Operating Income of Zhejiang Tianyuan Bio-Pharmaceutical, 2013-2014
- Assets and Liabilities of Zhejiang Tianyuan Bio-Pharmaceutical, 2013-2014
- Vaccine Lot Release Volume and Percentage of Kangtai Biological, 2007-2015
- Vaccine Lot Release Volume and Percentage of Hissen Bio-pharm, 2009-2015
- Vaccine Lot Release Volume of NCPC GeneTech Biotechnology Development, 2009-2015
- Lot Release Volume of Dalian Aleph Biomedical’s influenza split vaccine, 2009-2015
- Revenue and Operating Income of Dalian Aleph Biomedical, 2013-2014
- Assets and Liabilities of Dalian Aleph Biomedical, 2013-2014
- Vaccine Lot Release Volume Breakdown of Beijing Minhai Biotechnology by Product, 2009-2015
- Revenue and Operating Income of Beijing Minhai Biotechnology, 2013-2014
- Assets and Liabilities of Beijing Minhai Biotechnology, 2013-2014
- Vaccine Lot Release Volume Breakdown of Shenzhen Sanofi Pasteur Biological Products by Product, 2009-2015
- Revenue and Operating Income of Shenzhen Sanofi Pasteur Biological Products, 2013-2014
- Assets and Liabilities of Shenzhen Sanofi Pasteur Biological Products, 2013-2014

Note: Product cover images may vary from those shown
3 of 4

- Beijing Minhai Biotechnology Co., Ltd.
- Beijing Tiantan Biological Products Co., Ltd
- Changchun BCHT Biotechnology Co. Ltd.
- Changchun Changsheng Life Sciences Limited
- Changchun Institute of Biological Products Co., Ltd.
- Chengdu Institute of Biological Products Co., Ltd.
- China National Biotec Group
- Chongqing Zhifei Biological Products Co., Ltd.
- Dalian Aleph Biomedical Co., Ltd.
- Dalian Hissen Bio-Pharm Co., Ltd.
- Hualan Biological Engineering Inc.
- Jiangsu SimcereVaxtec Bio-pharmaceutical Co., Ltd.
- Lanzhou Institute of Biological Products Co., Ltd.
- Liaoning Cheng Da Co., Ltd.
- Liaoning Chengda Biotechnology Co., Ltd.
- NCPC GeneTech Biotechnology Development Co., Ltd.
- Shanghai Institute of Biological Products Co., Ltd.
- Shenzhen Kangtai Biological Products Co. Ltd.
- Shenzhen Sanofi Pasteur Biological Products Co., Ltd.
- Sinovac Biotech Ltd.
- Walvax Biotechnology Co, Ltd.
- Wuhan Institute of Biological Products Co., Ltd.
- Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

ALSO AVAILABLE

RELATED PRODUCTS from Db

Our Clients

  • AbbVie, Inc.
  • Hospira
  • Biocon
  • Celltrion
  • Bayer AG
  • Baxter International Inc.